Washington, United States,
08048034981
Noveltreat 0.25 mg  (semaglutide)
City Drug House – Type 2 Diabetes Pharma Exporter to USA

City Drug House is a trusted Indian pharmaceutical exporter specializing in Type 2 Diabetes medicines for the USA and Washington markets. We provide high-quality diabetic medications manufactured under strict quality standards with reliable international shipping.

Noveltreat (semaglutide) is a weekly injectable GLP-1 receptor agonist for managing type 2 diabetes and chronic weight management. A lower initial dosage is typically utilized as a starter dose to help manage blood sugar levels and control appetite while helping to manage gastrointestinal side effects.

Therapeutic Applications & Benefits :

1.Type 2 Diabetes Management: Improves glycemic control (HbA1c reduction) in adults when diet and exercise are insufficient.

2. Chronic Weight Management: Approved for reducing body weight in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with related conditions, such as high blood pressure or high cholesterol.

3.Mechanism of Action: Mimics the GLP-1 hormone to stimulate insulin release, reduce liver sugar production, and slow gastric emptying to increase satiety.

4.Cardiovascular Protection: Reduces the risk of major cardiovascular events (heart attack, stroke) in patients with diabetes.

City Drug House Exporters provides:

Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics

Contact for More Information :
📞 Contact City drug House Exporters from India

🌐 Websites:
https://www.citydrugexporters.com

📧 Email: citydrug123@gmail.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

📲 WhatsApp: +91 9975390171
May 16th, 2026 2:00 PM

Keywords